Medicare’s $274 negotiated Ozempic price takes effect January 1
Medicare’s negotiated price for Ozempic, Rybelsus and Wegovy takes effect January 1, 2027, at $274 for a 30-day supply, down from a 2024 list price of $959, according to the Centers for Medicare & Medicaid Services. The semaglutide drugs are among 15 medications whose second-round negotiated prices start that day in Medicare Part D. The…